Introverted scientist meets networking 👋

Introverted scientist meets networking 👋

New Year greetings to you!

To this day, the mere thought of going to a conference makes my heart rate go up.

And to my introverted self's dismay, gone are the days when scientists were seen as eccentric types who should be left alone to do their own work.

Nowadays, collaboration and networking are the key to success.  

GIF of Homer Simpson slowly backing into a bush. Homer is wearing his standard white polo and is staring into the abyss.

Don't get me wrong, there are aspects of going to conferences that I love. You can learn so much in a short timeit's like downing a triple shot espresso of scientific knowledge.

But early on in my career it felt exhausting and intimidating to put myself out there, especially when I saw name tags stating job titles like "Director" or "R&D Lead."

It wasn't until I found myself sitting next to a speaker with a high-profile name tag on the journey home from a conference that my perspective shifted.

I plucked up the courage to say hello, and we had a great chat. It turned out that despite years of experience in the field, he, too, sometimes felt apprehensive about networking.

He also thought job titles were an unnecessary barrier that limited the type of connections he could make, and he preferred conferences where they weren't shown.

Sharing that moment of vulnerability made me realize that no matter how senior the name tag, we all experience the same anxieties, and networking doesn't have to be as daunting as it appears to be.

While I'll probably never love it, if I hadn't pushed myself to start that conversation, I'd be much less at peace with that fact.

'Til the next one!

Luci, Senior Research Scientist, Synthace


🪄 AI isn't like waving a magic wand

Our Chief Scientific Officer Markus Gershater starts the year off right by saying it like it is. No method, AI included, can magically shine a light into biological complexity without multidimensional data.

Read his full post 

🤩 The Hamilton Microlab STAR in action

Customer Success Scientist Nathan Hardingham kicked off his mission to become an automation maestro in 2024, one device at a time, with a spotlight on Alexanderour affectionate name for the Hamilton Robotics Microlab STAR.       

Watch the Hamilton go 

🤖 Catch up: Running powerful, automated DOEs 

In the final webinar of our Automation Masterclass series last year, Markus Gershater delved into the team's decade of experience in running automated DOEs, sharing key lessons, powerful applications, and the best devices for running diverse multi-factorial experiments.    

Watch it on YouTube 


🔗 Content we're loving 

Design of Experiments for the automated development of a multicellular cardiac model for high-throughput screening

Why we loved it: It's great to see such a cool and important clinical application of Design of Experimentsand we promise we're not just saying that because the folks at GSK used Synthace DOE in combination with SPT Labtech 's dragonfly to make it happen.

They optimized a multicellular 2D monolayer model for cardiovascular toxicity testing, which replicates the complex interactions among different cell types in the heart, and doesn't suffer from the same throughput and cost limitations of 3D hPSC-derived models.

These interactions, which aren't represented in single cell cardiomyocyte models, can result in cardiotoxic effects being missed and promising drug candidates failing at the last stages of drug development.

Physical healing as a function of perceived time 

Why we loved it: They say time heals all woundsan expression that this study indicates doesn't just apply to mental wounds, but physical ones, too.

It found that wounds healed faster in participants who believed that more time had passed, compared to those who believed that less time had passed.

A fascinating finding, showing just how much our psychological state, including our perceptions and beliefs, can affect physiological outcomes.   

Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multicancer biomarker

Why we loved it: What if we could detect multiple fatal cancer types at an earlier stage, and make the diagnostic tests less invasive?

Researchers may be on the right track. They've developed a low-cost, rapid, and ultra-sensitive immunoassay, based on single molecule array (SIMOA) technology, which can detect the presence of ORF1p, a biomarker for multiple cancer types, within the bloodstream.  


About Synthace

Get faster, smarter insights from your R&D experiments. Designed by and for biologists, Synthace lets you design powerful experiments, run them in your lab, then automatically build structured data. No code necessary. Learn more.

Get the latest from our lab team

Scientists Luci and Fatima keep you posted on DOE, lab automation, plus all things current and future-facing in life sciences R&D. No frills. Only the important bits.

Subscribe for email updates here.

To view or add a comment, sign in

More articles by Synthace

Insights from the community

Others also viewed

Explore topics